Sara Alwarthan

627 total citations
21 papers, 230 citations indexed

About

Sara Alwarthan is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Sara Alwarthan has authored 21 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 7 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in Sara Alwarthan's work include COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Antibiotic Resistance in Bacteria (3 papers). Sara Alwarthan is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Antibiotic Resistance in Bacteria (3 papers). Sara Alwarthan collaborates with scholars based in Saudi Arabia, Pakistan and Malaysia. Sara Alwarthan's co-authors include Ali A. Rabaan, Amer Alshengeti, Mashael Alhajri, Mohammed Garout, Bashayer M. AlShehail, Shamsah H. Al-Ahmed, Abdulsalam Alawfi, Souad A. Almuthree, Muhammad A. Halwani and Ameen S. S. Alwashmi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and BMC Infectious Diseases.

In The Last Decade

Sara Alwarthan

20 papers receiving 224 citations

Peers

Sara Alwarthan

EPIDE

AMB

Fuad M. Alzahrani Saudi Arabia

Hawra Albayat Saudi Arabia

Abdulsalam Alawfi Saudi Arabia

Souad A. Almuthree Saudi Arabia

Juhi Sharma India

Minoosh Shabani Iran

Safaa A. Turkistani Saudi Arabia

Taciéli F. da Rosa Brazil

Rituparna De India

Michel F. Martínez‐Reséndez Mexico

Fuad M. Alzahrani Saudi Arabia

Sara Alwarthan

55 ×0.6

68 ×1.4

21 ×0.5

EPIDE

26 ×0.7

10 ×0.4

AMB

Citations per year, relative to Sara Alwarthan Sara Alwarthan (= 1×) peers Fuad M. Alzahrani

Countries citing papers authored by Sara Alwarthan

Since Specialization

Citations

This map shows the geographic impact of Sara Alwarthan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Alwarthan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Alwarthan more than expected).

Fields of papers citing papers by Sara Alwarthan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Alwarthan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Alwarthan. The network helps show where Sara Alwarthan may publish in the future.

Co-authorship network of co-authors of Sara Alwarthan

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Alwarthan. A scholar is included among the top collaborators of Sara Alwarthan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Alwarthan. Sara Alwarthan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alwarthan, Sara, et al.. (2025). Mortality and clinical outcomes of colistin versus colistin-based combination therapy for infections caused by Multidrug-resistant Acinetobacter baumannii in critically ill patients. BMC Infectious Diseases. 25(1). 416–416. 3 indexed citations

Rabaan, Ali A., Fatimah Alshahrani, Mohammed Garout, et al.. (2024). Repositioning of anti-infective compounds against monkeypox virus core cysteine proteinase: a molecular dynamics study. Molecular Diversity. 28(6). 4113–4135. 4 indexed citations

Rabaan, Ali A., Amal H. Alfaraj, Amer Alshengeti, et al.. (2023). Antibodies to Combat Fungal Infections: Development Strategies and Progress. Microorganisms. 11(3). 671–671. 10 indexed citations

Subbarayalu, Arun Vijay, et al.. (2023). Performance of CURB-65 and ISARIC 4C mortality scores for hospitalized patients with confirmed COVID-19 infection in Saudi Arabia. Informatics in Medicine Unlocked. 39. 101269–101269. 3 indexed citations

Rabaan, Ali A., Tarek Sulaiman, Shamsah H. Al-Ahmed, et al.. (2023). Potential Strategies to Control the Risk of Antifungal Resistance in Humans: A Comprehensive Review. Antibiotics. 12(3). 608–608. 28 indexed citations

Dhawan, Manish, Ali A. Rabaan, Sara Alwarthan, et al.. (2023). Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID. Vaccines. 11(3). 699–699. 41 indexed citations

Girija, A. S. Smiline, Shoba Gunasekaran, Mohammed Aljeldah, et al.. (2023). Prediction of Putative Epitope Peptides against BaeR Associated with TCS Adaptation in Acinetobacter baumannii Using an In Silico Approach. Medicina. 59(2). 343–343. 5 indexed citations

Basha, Sakeenabi, Ali A. Rabaan, Muhammad A. Halwani, et al.. (2023). Prevalence of Carbapenemase and Extended-Spectrum β-Lactamase Producing Enterobacteriaceae: A Cross-Sectional Study. Antibiotics. 12(1). 148–148. 16 indexed citations

Rabaan, Ali A., Muhammed A. Bakhrebah, Zuhair S. Natto, et al.. (2023). Unleashing the power of artificial intelligence for diagnosing and treating infectious diseases: A comprehensive review. Journal of Infection and Public Health. 16(11). 1837–1847. 14 indexed citations

10.

Alnimr, Amani, et al.. (2023). Microbiological trends and mortality risk factors of central line-associated bloodstream infections in an academic medical center 2015–2020. Antimicrobial Resistance and Infection Control. 12(1). 128–128. 10 indexed citations

11.

Alhassan, Mohammad, et al.. (2023). Pharmacist-led education curriculum for fourth-year medical students: a single-center experience. Pharmacy Practice. 21(3). 1–8.

12.

Almuqbil, Mansour, Mohd Imran, Mehnaz Kamal, et al.. (2023). Role of Natural Products in the Management of COVID-19: A Saudi Arabian Perspective. Healthcare. 11(11). 1584–1584. 2 indexed citations

13.

Alkhafaji, Dania, et al.. (2022). The Impact of Vitamin D Level on the Severity and Outcome of Hospitalized Patients with COVID-19 Disease. SHILAP Revista de lepidopterología. 20 indexed citations

14.

Rabaan, Ali A., Saad Alhumaid, Hawra Albayat, et al.. (2022). Promising Antimycobacterial Activities of Flavonoids against Mycobacterium sp. Drug Targets: A Comprehensive Review. Molecules. 27(16). 5335–5335. 16 indexed citations

15.

Rabaan, Ali A., Muhammed A. Bakhrebah, Ranjan K. Mohapatra, et al.. (2022). Omics Approaches in Drug Development against Leishmaniasis: Current Scenario and Future Prospects. Pathogens. 12(1). 39–39. 3 indexed citations

16.

Rabaan, Ali A., Abbas Al Mutair, Mohammed Aljeldah, et al.. (2022). Genetic Variants and Protective Immunity against SARS-CoV-2. Genes. 13(12). 2355–2355. 3 indexed citations

17.

Alnimr, Amani, et al.. (2022). Bacterial and Fungal Coinfection in Critically Ill COVID-19 Cases and Predictive Role of Procalcitonin During the First Wave at an Academic Health Center. Journal of Epidemiology and Global Health. 12(2). 188–195. 12 indexed citations

18.

Yusof, Nik Yusnoraini, Fatin Hamimi Mustafa, Naveed Ahmed, et al.. (2022). Prevalence of Mutated Colistin-Resistant Klebsiella pneumoniae: A Systematic Review and Meta-Analysis. Tropical Medicine and Infectious Disease. 7(12). 414–414. 18 indexed citations

19.

Ahmed, Naveed, Mai Abdel Haleem Abusalah, Muhammad Absar, et al.. (2022). Updates on Epstein–Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV. Medicina. 59(1). 2–2. 10 indexed citations

20.

Rabaan, Ali A., Abbas Al Mutair, Khalid Hajissa, et al.. (2022). A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants. Vaccines. 10(10). 1655–1655. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact